Get Published | Subscribe | About | Write for Our Blog    

News RSS Bioethics News.


New treatments for peanut allergies sound promising, but questions remain

External Link - Source: The Washington Post

Brisbane, Calif.-based Aimmune Therapeutics recently sparked optimistic headlines after releasing clinical trial results that its allergy product, AR101, would reduce the risks linked to an accidental exposure to peanuts.

This entry was posted in Stem Cells, Technology and tagged . Bookmark the permalink.